Xcellerex Initiates Phase I Clinical Trial of Yellow Fever Vaccine

News   Jan 13, 2010

 
Xcellerex Initiates Phase I Clinical Trial of Yellow Fever Vaccine
 
 
 

RELATED ARTICLES

Developing a Gene Therapy for Deaf Patients

News

OSU researchers have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

READ MORE

CRISPR Reveals the Sugary Secrets of the Cancer-related Notch Protein

News

New research shows that the fucose and glucose modifications serve as quality-control markers that allow Notch to be transported to its final destination in the cell membrane.

READ MORE

Autism Risk Higher if Pregnant Mothers Have Infection Requiring Hospitalization

News

Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE